Terms: = Breast cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Treatment
50 results:
1. Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive breast cancer.
Goldberg J; Qiao N; Guerriero JL; Gross B; Meneksedag Y; Lu YF; Philips AV; Rahman T; Meric-Bernstam F; Roszik J; Chen K; Jeselsohn R; Tolaney SM; Peoples GE; Alatrash G; Mittendorf EA
Cancer Res Commun; 2024 Feb; 4(2):496-504. PubMed ID: 38335301
[TBL] [Abstract] [Full Text] [Related]
2. Skin-Grafting and Dendritic Cell "Boosted" Humanized Mouse Models Allow the Pre-Clinical Evaluation of Therapeutic cancer Vaccines.
Zeng B; Moi D; Tolley L; Molotkov N; Frazer IH; Perry C; Dolcetti R; Mazzieri R; Cruz JLG
Cells; 2023 Aug; 12(16):. PubMed ID: 37626903
[TBL] [Abstract] [Full Text] [Related]
3. Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic cancer.
Tsimberidou AM; Guenther K; Andersson BS; Mendrzyk R; Alpert A; Wagner C; Nowak A; Aslan K; Satelli A; Richter F; Kuttruff-Coqui S; Schoor O; Fritsche J; Coughlin Z; Mohamed AS; Sieger K; Norris B; Ort R; Beck J; Vo HH; Hoffgaard F; Ruh M; Backert L; Wistuba II; Fuhrmann D; Ibrahim NK; Morris VK; Kee BK; Halperin DM; Nogueras-Gonzalez GM; Kebriaei P; Shpall EJ; Vining D; Hwu P; Singh H; Reinhardt C; Britten CM; Hilf N; Weinschenk T; Maurer D; Walter S
Cancer Immunol Res; 2023 Jul; 11(7):925-945. PubMed ID: 37172100
[TBL] [Abstract] [Full Text] [Related]
4. Development of the oncolytic virus, CF33, and its derivatives for peritoneal-directed treatment of gastric cancer peritoneal metastases.
Yang A; Zhang Z; Chaurasiya S; Park AK; Jung A; Lu J; Kim SI; Priceman S; Fong Y; Woo Y
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37019471
[TBL] [Abstract] [Full Text] [Related]
5. Transcriptomic and Functional Evidence That miRNA193a-3p Inhibits Lymphatic Endothelial Cell (LEC) and LEC + MCF-7 Spheroid Growth Directly and by Altering MCF-7 Secretome.
Azzarito G; Henry M; Rotshteyn T; Leeners B; Dubey RK
Cells; 2023 Jan; 12(3):. PubMed ID: 36766731
[TBL] [Abstract] [Full Text] [Related]
6. Quantitative immunopeptidomics reveals a tumor stroma-specific target for T cell therapy.
Kim GB; Fritsche J; Bunk S; Mahr A; Unverdorben F; Tosh K; Kong H; Maldini CR; Lau C; Srivatsa S; Jiang S; Glover J; Dopkin D; Zhang CX; Schuster H; Kowalewski DJ; Goldfinger V; Ott M; Fuhrmann D; Baues M; Boesmueller H; Schraeder C; Schimmack G; Song C; Hoffgaard F; Roemer M; Tsou CC; Hofmann M; Treiber T; Hutt M; Alten L; Jaworski M; Alpert A; Missel S; Reinhardt C; Singh H; Schoor O; Walter S; Wagner C; Maurer D; Weinschenk T; Riley JL
Sci Transl Med; 2022 Aug; 14(660):eabo6135. PubMed ID: 36044599
[TBL] [Abstract] [Full Text] [Related]
7. Adoptive Cellular Therapy with Autologous Tumor-Infiltrating Lymphocytes and T-cell Receptor-Engineered T Cells Targeting Common p53 Neoantigens in Human Solid Tumors.
Kim SP; Vale NR; Zacharakis N; Krishna S; Yu Z; Gasmi B; Gartner JJ; Sindiri S; Malekzadeh P; Deniger DC; Lowery FJ; Parkhurst MR; Ngo LT; Ray S; Li YF; Hill V; Florentin M; Masi RV; Paria BC; Levin N; Bera A; Hedges EA; Choi A; Chatani PD; Parikh AY; Levi S; Seitter S; Lu YC; Zheng Z; Prickett TD; Jia L; Hernandez JM; Hoang CD; Robbins PF; Goff SL; Sherry RM; Yang JC; Rosenberg SA
Cancer Immunol Res; 2022 Aug; 10(8):932-946. PubMed ID: 35749374
[TBL] [Abstract] [Full Text] [Related]
8. Results of the implementation of a pharmacogenomics platform based on NGS technologies. Combining clinical and research approaches.
Ramudo-Cela L; Busto-Fernández F; Outeda-Macías M; Antolín S; Calvo-Martínez L; Martín-Herranz I
Farm Hosp; 2021 Dec; 45(7):11-37. PubMed ID: 35379108
[TBL] [Abstract] [Full Text] [Related]
9. Transcriptomic Analysis of breast cancer Patients Sensitive and Resistant to Chemotherapy: Looking for Overall Survival and Drug Resistance Biomarkers.
Barrón-Gallardo CA; Garcia-Chagollán M; Morán-Mendoza AJ; Delgadillo-Cristerna R; Martínez-Silva MG; Aguilar-Lemarroy A; Jave-Suárez LF
Technol Cancer Res Treat; 2022; 21():15330338211068965. PubMed ID: 34981997
[TBL] [Abstract] [Full Text] [Related]
10. The Association of Estrogen Receptor Activity, Interferon Signaling, and MHC Class I Expression in breast cancer.
Song IH; Kim YA; Heo SH; Bang WS; Park HS; Choi YH; Lee H; Seo JH; Cho Y; Jung SW; Kim HJ; Ahn SH; Lee HJ; Gong G
Cancer Res Treat; 2022 Oct; 54(4):1111-1120. PubMed ID: 34942685
[TBL] [Abstract] [Full Text] [Related]
11. Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative breast cancer.
Sinn BV; Loibl S; Hanusch CA; Zahm DM; Sinn HP; Untch M; Weber K; Karn T; Becker C; Marmé F; Schmitt WD; Müller V; Schem C; Treue D; Stickeler E; Klauschen F; Burchardi N; Furlanetto J; van Mackelenbergh M; Fasching PA; Schneeweiss A; Denkert C
Clin Cancer Res; 2021 May; 27(9):2584-2591. PubMed ID: 33593886
[TBL] [Abstract] [Full Text] [Related]
12. Geospatial barriers to healthcare access for breast cancer diagnosis in sub-Saharan African settings: The African breast cancer-Disparities in Outcomes Cohort Study.
Togawa K; Anderson BO; Foerster M; Galukande M; Zietsman A; Pontac J; Anele A; Adisa C; Parham G; Pinder LF; McKenzie F; Schüz J; Dos Santos-Silva I; McCormack V
Int J Cancer; 2021 May; 148(9):2212-2226. PubMed ID: 33197280
[TBL] [Abstract] [Full Text] [Related]
13. ZNRD1 and Its Antisense Long Noncoding RNA ZNRD1-AS1 Are Oppositely Regulated by Cold Atmospheric Plasma in breast cancer Cells.
Kim HW; Jeong D; Ham J; Kim H; Ji HW; Choi EH; Kim SJ
Oxid Med Cell Longev; 2020; 2020():9490567. PubMed ID: 32454947
[TBL] [Abstract] [Full Text] [Related]
14. MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma.
Engelhard VH; Obeng RC; Cummings KL; Petroni GR; Ambakhutwala AL; Chianese-Bullock KA; Smith KT; Lulu A; Varhegyi N; Smolkin ME; Myers P; Mahoney KE; Shabanowitz J; Buettner N; Hall EH; Haden K; Cobbold M; Hunt DF; Weiss G; Gaughan E; Slingluff CL
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32385144
[TBL] [Abstract] [Full Text] [Related]
15. Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma.
Murata K; Nakatsugawa M; Rahman MA; Nguyen LT; Millar DG; Mulder DT; Sugata K; Saijo H; Matsunaga Y; Kagoya Y; Guo T; Anczurowski M; Wang CH; Burt BD; Ly D; Saso K; Easson A; Goldstein DP; Reedijk M; Ghazarian D; Pugh TJ; Butler MO; Mak TW; Ohashi PS; Hirano N
Elife; 2020 Apr; 9():. PubMed ID: 32314731
[TBL] [Abstract] [Full Text] [Related]
16. Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy.
Sinn BV; Weber KE; Schmitt WD; Fasching PA; Symmans WF; Blohmer JU; Karn T; Taube ET; Klauschen F; Marmé F; Schem C; Stickeler E; Ataseven B; Huober J; von Minckwitz G; Seliger B; Denkert C; Loibl S
Breast Cancer Res; 2019 Dec; 21(1):142. PubMed ID: 31829264
[TBL] [Abstract] [Full Text] [Related]
17. Delayed IL-21 treatment preferentially expands peptide-specific CD8
Kim SH; Park SY; Lim MC; Lee ES; Lee EG; Han SE; Kim YH; Kwon BS; Choi BK
Immunotherapy; 2019 Apr; 11(6):497-513. PubMed ID: 30760061
[TBL] [Abstract] [Full Text] [Related]
18. A prospective and population-based inquiry on the use and acceptability of peer support for women newly diagnosed with breast cancer.
Legg M; Hyde MK; Occhipinti S; Youl PH; Dunn J; Chambers SK
Support Care Cancer; 2019 Feb; 27(2):677-685. PubMed ID: 30056530
[TBL] [Abstract] [Full Text] [Related]
19. IgG response to MHC class I epitope peptides is a quantitative predictive biomarker in the early course of treatment of colorectal cancer using therapeutic peptides.
Kanekiyo S; Hazama S; Takenouchi H; Nakajima M; Shindo Y; Matsui H; Tokumitsu Y; Tomochika S; Tsunedomi R; Tokuhisa Y; Iida M; Sakamoto K; Suzuki N; Takeda S; Yamamoto S; Yoshino S; Okuno K; Udaka K; Kawakami Y; Matsueda S; Ito K; Nagano H
Oncol Rep; 2018 May; 39(5):2385-2392. PubMed ID: 29498403
[TBL] [Abstract] [Full Text] [Related]
20. Cytotoxic T lymphocyte response to peptide vaccination predicts survival in stage III colorectal cancer.
Kawamura J; Sugiura F; Sukegawa Y; Yoshioka Y; Hida JI; Hazama S; Okuno K
Cancer Sci; 2018 May; 109(5):1545-1551. PubMed ID: 29473265
[TBL] [Abstract] [Full Text] [Related]
[Next]
